Dominique Pasquier

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

45h-index8.8kcitations694works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(110), Advanced Radiotherapy Techniques(108), Prostate Cancer Treatment and Research(98), Education, sociology, and vocational training(72), French Urban and Social Studies(61)

Publications690 total

Clinical practice, barriers to implementation, and priorities for equitable access of Stereotactic Body Radiation Therapy: An analysis of the global status by the ESTRO SBRT Focus Group
Clinical and Translational Radiation Oncology·2025Open Access
Adjuvant radiotherapy in patients with pathological high-risk bladder cancer: Acute toxicity results from a randomized multicentre phase II trial (Bladder-ART/GETUG-AFU30)
Radiotherapy and Oncology·2025
Stereotactic re-irradiation for lymph node recurrence of breast cancer
BMC Cancer·2025Open Access
SBRT in oligometastatic castration-resistant prostate cancer
The Lancet Oncology·2025
Reirradiation of lung, breast and bone tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique
Cancer/Radiothérapie·2025
Reirradiation of prostate, gynaecologic and pelvic tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologique
Cancer/Radiothérapie·2025
Radiotherapy of breast cancer: 2025 update
Cancer/Radiothérapie·2025· 1 citedOpen Access
Comprehensive radiotherapy quality assurance analysis from individual DICOM data in the HypoG-01 phase 3 trial
Radiotherapy and Oncology·2025· 2 cited
Quality assurance of contouring and dosimetric consistency in the GETUG-AFU 31 salvage prostate stereotactic reirradiation trial
Radiotherapy and Oncology·2025
Apprendre par la bande
Réseaux·2025
CN58 After breast cancer: Implementation of coordinated care and patient satisfaction survey
Annals of Oncology·2025
Stereotactic radiotherapy for lung cancer: Influence of prescription modality on clinical outcome
Cancer/Radiothérapie·2025Open Access
Stereotactic radiotherapy for prostate cancer
Cancer/Radiothérapie·2025
Breast cancer tumour board: Which patients are eligible for radiotherapy de-escalation or omission?
Cancer/Radiothérapie·2025· 2 cited
Abstract P3-08-03: Trends in Presentation of HER2+ Breast Cancer: A Retrospective study of De Novo Versus Recurrent Metastatic Breast Cancer (MBC) in the Real-World French National ESME Cohort (2008-2022)
Clinical Cancer Research·2025
Radiation therapy of the primary tumor and/or metastases of digestive metastatic cancers (colon cancers excluded)
Hépato-Gastro & Oncologie Digestive·2025
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types
CA A Cancer Journal for Clinicians·2025· 6 citedOpen Access
3964 Cost-effectiveness of locoregional hypofractionated RT in early breast cancer: evaluation alongside the HypoG-01 phase 3 Unicancer trial
Radiotherapy and Oncology·2025
1578 Pushing the boundaries of SBRT in irradiated territories for nodal oligorecurrent prostate cancer: outcomes of the CYGNUS retrospective study
Radiotherapy and Oncology·2025· 1 cited
687 Salvage treatment for HER2+/Triple negative 2nd ipsilateral breast cancer event: A propensity scorematched cohort analysis of the GEC-ESTRO database
Radiotherapy and Oncology·2025
page 1 of 35Next →

Frequent Co-authors

B Pasquier(6), Thomas Zilli(5), T. Lacornerie(5), S. Supiot(4), Florence Dalenc(4), Thierry Petit(4), Barbara Alicja Jereczek‐Fossa(4), Piet Ost(4), Éric Lartigau(4), Jean‐Michel Hannoun‐Lévi(4), Paul Sargos(3), Marlon Silva(3), S. Villà(3), Amélie Darlix(3), Anthony Gonçalvès(3), Mario Campone(3), Paule Augereau(3), Jean-David Fumet(3), Lionel Uwer(3), Christelle Jouannaud(3)